TY  - JOUR
AU  - Rivera-Caravaca, José Miguel
AU  - Camelo-Castillo, Anny
AU  - Ramírez-Macías, Inmaculada
AU  - Gil-Pérez, Pablo
AU  - López-García, Cecilia
AU  - Esteve-Pastor, María Asunción
AU  - Orenes-Piñero, Esteban
AU  - Tello-Montoliu, Antonio
AU  - Marín, Francisco
PY  - 2021
DO  - 10.3390/ijms22137113
UR  - https://hdl.handle.net/10668/28048
T2  - International journal of molecular sciences
AB  - Peripheral artery disease (PAD) is a major cause of morbidity and mortality but it is usually underdiagnosed and undertreated. Patients with PAD present dysregulated procoagulant, anticoagulant, and fibrinolytic pathways leading to arterial and venous...
LA  - en
KW  - anticoagulation therapy
KW  - antiplatelet therapy
KW  - peripheral artery disease
KW  - rivaroxaban
KW  - Anticoagulants
KW  - Aspirin
KW  - Blood Coagulation
KW  - Drug Therapy, Combination
KW  - Factor Xa Inhibitors
KW  - Fibrinolytic Agents
KW  - Humans
KW  - Peripheral Arterial Disease
KW  - Platelet Aggregation Inhibitors
KW  - Rivaroxaban
KW  - Thrombolytic Therapy
KW  - Thrombosis
TI  - Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation.
TY  - research article
VL  - 22
ER  -